Van Eck's Egypt ETF Suspends Creation Orders
Investors still can redeem their shares in the fund.
Investors still can redeem their shares in the fund.
Today, Van Eck Global announced that owing to the current turmoil in Egypt (and the closure of the country's equity exchange), Van Eck has suspended creation orders in Market Vectors Egypt Index ETF . However, Van Eck also announced today that it is continuing to allow investors to redeem their shares in EGPT (which as of this writing was up about 6% on the day, on heavy volumes), per the fund's prospectus.
"Van Eck Global will exercise its right to suspend creation orders of Market Vectors Egypt Index ETF," the firm said in a press release. "This follows the firm's normal policy of suspending creation orders when the underlying market is closed for an extended period thereby helping to prevent the costs of creation activity to be borne by existing shareholders."
What does this mean for investors? As we have seen in previous (but very different) situations in which ETF providers allow redemptions while halting creation orders, it typically prevents an ETF from trading at a large discount, but it does allow an ETF to trade at an at-times substantial premium to the value of its underlying stock holdings (as no authorized participants can arbitrage away the premium by creating new shares and selling them until the premium disappears). Such has been happening recently, so EGPT is effectively functioning as a closed-end fund.
With between $11 million and $12 million in assets, EGPT ordinarily is a fairly thinly traded ETF.
The NYSE Arca halted trading in EGPT before the market open on Monday, on news pending, which turned out to be Van Eck's announcement. The NYSE Arca allowed trading to resume at 11:30 a.m. Eastern time.
Van Eck also noted that EGPT "expects to resume normal operations once the Egyptian Stock Exchange reopens."
Trading has not been halted in other ETFs with meaningful exposures to Egypt, including PowerShares MENA Frontier Countries Portfolio , which has more than 16% of its assets invested in companies based in Egypt; Guggenheim Frontier Markets , which has a nearly 13% exposure to Egypt; Market Vectors Africa Index ETF (AFK), which has more than 20% exposure to Egyptian companies; or WisdomTree Middle East Dividend , which has a nearly 10% exposure to Egypt.
ETFInvestor Newsletter | ||||
Let our new newsletter, Morningstar ETFInvestor, help you navigate the exciting and new world of exchange-traded funds. Each issue includes recommendations for commonsense ETF investing, | ETF spotlights, and critical data on 150 top ETFs. This one-year subscription consists of 12 monthly issues. Learn more. | |||
$185.00 for 12 Print Issues | $175 for 12 PDF Issues | |||
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.